These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4949645)

  • 21. Experimental pyelonephritis in primates.
    Schoonees R; Neter E; Murphy GP
    J Med; 1972; 3(6):363-72. PubMed ID: 4203808
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunosuppressive treatment of experimental pyelonephritis with a combination of oxytetracycline and azathioprine.
    Hagemann I; Philipp H; Briedigkeit H; Dutz H
    Clin Nephrol; 1973; 1(6):372-6. PubMed ID: 4594998
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental studies on the etiology and pathogenesis of pyelonephritis].
    Mohr HJ
    Beitr Pathol Anat; 1969; 138(4):357-76. PubMed ID: 4239799
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on pyelitis and pyelonephritis--especially on the mechanism of hematogenous infections and summation].
    Iwata S
    Iryo; 1970 Jul; 24(7):539-45. PubMed ID: 4917790
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of cyclophosphamide in experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Eksp Med Morfol; 1984; 23(4):186-95. PubMed ID: 6396063
    [No Abstract]   [Full Text] [Related]  

  • 26. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
    Gupta R; Ganguly NK; Ahuja V; Joshi K; Sharma S
    J Med Microbiol; 1995 Jul; 43(1):33-6. PubMed ID: 7608952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
    Kaboré AF; Simard M; Bergeron MG
    J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
    Prát V; Konícková L; Hatala M
    Arzneimittelforschung; 1970 Apr; 20(4):554-7. PubMed ID: 4911591
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
    Rudzit EA; Lisitsa LI
    Farmakol Toksikol; 1971; 34(2):246-50. PubMed ID: 4998195
    [No Abstract]   [Full Text] [Related]  

  • 30. Contributions to the development of experimental pyelonephritis.
    Ormos J; Csapó Z; Lantos J
    Acta Morphol Acad Sci Hung; 1968; 16(1):85-101. PubMed ID: 4879357
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic pyelonephritis. Electron microscopic study. II. Persistence of variant bacterial forms.
    Smith TW; Roberts JA
    Invest Urol; 1978 Sep; 16(2):154-62. PubMed ID: 361629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathomorphologic characteristics of hematogenous colibacillary pyelonephritis in rats].
    Starkov MV; Boguslavskaia ES; Lisitsa LI
    Biull Eksp Biol Med; 1973 Mar; 75(1):111-4. PubMed ID: 4591625
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathobiology of subclinical pyelonephritis--an experimental evaluation.
    Miller TE; Findon G; Rainer SP; Gavin JB
    Kidney Int; 1992 May; 41(5):1356-65. PubMed ID: 1614050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental pyelonephritis in mice following ascending infection with E. coli. Chronic phase.
    Tanaka N; Une T; Ogawa H
    Acta Pathol Jpn; 1981 Mar; 31(2):189-98. PubMed ID: 7020332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil recruitment and resistance to urinary tract infection.
    Haraoka M; Hang L; Frendéus B; Godaly G; Burdick M; Strieter R; Svanborg C
    J Infect Dis; 1999 Oct; 180(4):1220-9. PubMed ID: 10479151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats].
    Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):40-3. PubMed ID: 3511839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria.
    Matsumoto T; Mitzunoe Y; Ogata N; Tanaka M; Takahashi K; Kumazawa J
    Nephron; 1992; 60(2):210-5. PubMed ID: 1348108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for obstructive etiology in intravenous bacterial pyelonephritis.
    Fry TL; Fried FA; Goven BA
    J Surg Res; 1975 Mar; 18(3):277-84. PubMed ID: 1094197
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hematogenous Coli pyelonephritis in rabbits following kidney puncture and incision. Significance of the interval between the operation and bacteremia].
    Ditscherlein G; Philipp H; Briedigkeit H
    Z Urol Nephrol; 1974 Nov; 67(11):829-39. PubMed ID: 4618011
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bacterial phagocytosis of the proximal convoluted tubules in experimental pyelonephritis].
    Iványi B; Krenács T; Petri S; Lantos J
    Morphol Igazsagugyi Orv Sz; 1986 Jan; 26(1):25-32. PubMed ID: 3512980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.